About you
Which best describes your response?
Please select one item
(Required)
Radio button:
Ticked
I am responding as an individual
Radio button:
Unticked
I am responding on behalf of an organisation / institution
Individual
Which best describes you?
Please select one item
Radio button:
Unticked
Consumer / patient
Radio button:
Ticked
Registered healthcare professional
Radio button:
Unticked
Professional researcher
Radio button:
Unticked
None of the above / I am responding out of personal interest
Your response - Part A
Do you support the interim decision made in relation to the below substances?
| Item 2.1 - Amygdalin and hydrocyanic acid No comment Radio button: Checked No comment | Item 2.1 - Amygdalin and hydrocyanic acid Fully support Radio button: Not checked Fully support | Item 2.1 - Amygdalin and hydrocyanic acid Partially support Radio button: Not checked Partially support | Item 2.1 - Amygdalin and hydrocyanic acid Oppose Radio button: Not checked Oppose |
| Item 2.2 - Bilastine No comment Radio button: Checked No comment | Item 2.2 - Bilastine Fully support Radio button: Not checked Fully support | Item 2.2 - Bilastine Partially support Radio button: Not checked Partially support | Item 2.2 - Bilastine Oppose Radio button: Not checked Oppose |
| Item 2.3 - Budesonide + formoterol No comment Radio button: Checked No comment | Item 2.3 - Budesonide + formoterol Fully support Radio button: Not checked Fully support | Item 2.3 - Budesonide + formoterol Partially support Radio button: Not checked Partially support | Item 2.3 - Budesonide + formoterol Oppose Radio button: Not checked Oppose |
| Item 2.4 - Psilocybin No comment Radio button: Not checked No comment | Item 2.4 - Psilocybin Fully support Radio button: Not checked Fully support | Item 2.4 - Psilocybin Partially support Radio button: Not checked Partially support | Item 2.4 - Psilocybin Oppose Radio button: Not checked Oppose |
| Item 2.5 - N, α-Dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) No comment Radio button: Not checked No comment | Item 2.5 - N, α-Dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) Fully support Radio button: Not checked Fully support | Item 2.5 - N, α-Dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) Partially support Radio button: Not checked Partially support | Item 2.5 - N, α-Dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) Oppose Radio button: Not checked Oppose |
| Item 3.1 - Azoxystrobin No comment Radio button: Checked No comment | Item 3.1 - Azoxystrobin Fully support Radio button: Not checked Fully support | Item 3.1 - Azoxystrobin Partially support Radio button: Not checked Partially support | Item 3.1 - Azoxystrobin Oppose Radio button: Not checked Oppose |
| Item 3.2 - Triticonazole No comment Radio button: Checked No comment | Item 3.2 - Triticonazole Fully support Radio button: Not checked Fully support | Item 3.2 - Triticonazole Partially support Radio button: Not checked Partially support | Item 3.2 - Triticonazole Oppose Radio button: Not checked Oppose |
| Item 4.1 - Azelaic acid No comment Radio button: Checked No comment | Item 4.1 - Azelaic acid Fully support Radio button: Not checked Fully support | Item 4.1 - Azelaic acid Partially support Radio button: Not checked Partially support | Item 4.1 - Azelaic acid Oppose Radio button: Not checked Oppose |
| Item 4.2 - 2-hydroxyethyl methacrylate No comment Radio button: Checked No comment | Item 4.2 - 2-hydroxyethyl methacrylate Fully support Radio button: Not checked Fully support | Item 4.2 - 2-hydroxyethyl methacrylate Partially support Radio button: Not checked Partially support | Item 4.2 - 2-hydroxyethyl methacrylate Oppose Radio button: Not checked Oppose |
| Item 4.3 - Magnesium hydroxide No comment Radio button: Checked No comment | Item 4.3 - Magnesium hydroxide Fully support Radio button: Not checked Fully support | Item 4.3 - Magnesium hydroxide Partially support Radio button: Not checked Partially support | Item 4.3 - Magnesium hydroxide Oppose Radio button: Not checked Oppose |
| Item 4.4 - Tetrahydrofurfuryl alcohol (THFA) No comment Radio button: Checked No comment | Item 4.4 - Tetrahydrofurfuryl alcohol (THFA) Fully support Radio button: Not checked Fully support | Item 4.4 - Tetrahydrofurfuryl alcohol (THFA) Partially support Radio button: Not checked Partially support | Item 4.4 - Tetrahydrofurfuryl alcohol (THFA) Oppose Radio button: Not checked Oppose |
| Item 4.5 - Cannabidiol (private application) No comment Radio button: Checked No comment | Item 4.5 - Cannabidiol (private application) Fully support Radio button: Not checked Fully support | Item 4.5 - Cannabidiol (private application) Partially support Radio button: Not checked Partially support | Item 4.5 - Cannabidiol (private application) Oppose Radio button: Not checked Oppose |
Your response - Part B (written submission)
Write your response here.
Written submission
As a clinical psychologist abd supervisor of clinicians for 24 years, having worked primarily with PTSD and treatment resistant trauma as well as a researcher trained in working with people in the states of consciousness that these substances can elicit- it is essential that we make these substances available for people suffering from trauma, PTSD and addiction. These treatments will offer hope and healing for people whose suffering is profound and resistant to existing treatment methods and whose suicide rates are alarming. Making these new therapies available is a humane, evidenced based, and compassionate decision.